Search

everythinglearnresearchcommunity

for

Search:↓

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

The document is a detailed medical reference on skin and genetic disorders.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Heparan sulfate is important for hair growth, preventing new hair formation in mature skin, and controlling oil gland development.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Allergic cats with yeast overgrowth improved with antifungal treatment.

Some cats with sudden hair loss and tiredness might have cancer-related alopecia.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

The dog's skin and anemia issues returned after stopping treatment for Babesia gibsoni.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

The document concludes that various disorders can cause hair loss in dogs, each requiring different treatments, and some may heal on their own.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Wnt, Eda, and Shh pathways are crucial for different stages of sweat gland development in mice.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Fat cells are important for tissue repair and stem cell support in various body parts.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.